Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0000899243-16-017730)

Filing Details

Accession Number:: 0000899243-16-017730
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2016-04-06 17:44:19
Reporting Period:: 2016-04-04

Filing Date:: 2016-04-06
Accepted Time:: 2016-04-06 17:44:19
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1609809	Seres Therapeutics Inc.	MCRB	Pharmaceutical Preparations (2834)	274326290

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1643734	D. Eric Shaff	C/O Seres Therapeutics, Inc. 215 First Street Cambridge MA 02142	Cfo And Evp	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2016-04-04	6,568	$7.79	6,568	No	4	M	Direct
Common Stock	Disposition	2016-04-04	6,568	$28.85	0	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (right to buy)	Disposition	2016-04-04	6,568	$0.00	6,568	$7.79

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
242,988		2024-12-08	No	4	M	Direct

Footnotes

The sale reported in the Form 4 was effected pursuant to a Rule 10b5 1 trading plan adopted on February 26, 2016 by the Reporting Person.
The option vested as to 25% of the shares subject to the option on November 17, 2015, and has vested or will vest as to an additional 6.25% of the total number of shares subject to the option upon the completion of each three consecutive months of service thereafter.